Gene Therapy Safety: A joint investigation reports a 6-year-old girl in China died within a week after an experimental gene therapy for a rare disorder, reigniting scrutiny of gene-therapy oversight. FDA & Peptides: A US advisory panel narrowly backed easing restrictions on injectable peptides popular with wellness influencers, a move that could expand telehealth marketing despite safety concerns. Sweeteners & Gut Health: A new study links several commercially used sweeteners to slowed or halted growth of beneficial gut bacteria, with stronger effects when combined with certain compounds or drugs. AI Governance & Companions: China’s AI companion rules are tightening after concerns about addiction and social harm, while global debate grows over how to govern increasingly capable AI systems. Biopharma Manufacturing: US FDA completed a successful inspection of Asymchem’s carbapenem API site in China, marking a key regulatory milestone for advanced continuous-flow production. Pediatric Auto-Inflammation: Chinese researchers published a clinical framework mapping pediatric Behçet’s spectrum disorders to improve early recognition and genetic prioritization. Foreigners’ Services: SinoGuide launched a one-stop app for foreign nationals in China, bundling payments, transport, healthcare info, and policy reminders.